Patient Engagement Analysis Helped a Global Pharma Company Improve Conversion Rates and Patient Satisfaction | Quantzig’s Success Story Offers In-depth Insights

LONDON–(BUSINESS WIRE)–Feb 3, 2021–
Quantzig, advanced analytics and business intelligence solution provider, announced today the release of its latest patient engagement analysis success story that sheds light on the importance of healthcare analytics in the healthcare sector.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210203005424/en/
The success story sheds light on how a leading American pharmaceutical company leveraged patient engagement analysis to improve patient engagement. Today pharmaceutical companies are working on improving the patient experience. Quantzig’s patient engagement analysis focuses on driving healthcare transformation to improve patient outcomes and reduce costs. This success story sheds light on the importance of patient engagement analysis in boosting operational efficiency. Read the success story here:
Request a FREE proposalto understand the potential benefits of patient engagement analysis.
Challenges faced by the pharmaceutical company included-

  • Rising costs and the need to improve healthcare outcomes
  • Improve the effectiveness and efficacy of patient outreach
  • Analyze the patient data and effectively target patients to deliver top-notch services
  • Improve patient engagement in a cost-effective manner

Over the past 16 years, Quantzig has helped leading pharmaceutical companies to solve some of the most challenging business problems leveraging patient engagement analysis solutions. Want to know more? Contact us.
The client is a leading US-based pharma company well-known for its quality control standards in medicine. This leading pharma company collaborated with Quantzig to leverage its patient engagement analysis expertise to improve patient engagement, experience, and business outcomes.
Request a FREE pilotto know how Quantzig’s data-driven approach can help you improve the efficiency of patient outreach using patient engagement analysis.
How did patient engagement analysis help the pharmaceutical firm?
The patient engagement analysis experts of Quantzig conducted a pilot to test the patient engagement model results parallelly along with the existing rule-based calling campaign to compare the results of the analytical approach and measure its success. The solution offered by Quantzig helped this pharmaceutical giant improve conversion rates for the selected group patients by 35%.
The patient engagement analysis solution also helped the client to-

  • Improve customer satisfaction rates by offering services in real-time through the preferred channel
  • Witness a 3x boost in operational efficiency

Recent success stories that might interest you-

Follow us on LinkedIn and Twitter to keep abreast of the upcoming trends in business intelligence and analytics.
About Quantzig
Quantzig is the world’s foremost full-service advanced analytics and business intelligence solution provider, turning clients’ complex, unstructured data into intelligent, actionable insights that enable them to solve complex business problems and inspire innovation, change, and growth.
Over the past 16 years, our insights have helped over 120 clients spanning across industries and sectors like Pharmaceutical and Life Sciences, Retail and CPG, Food and Beverage, and more. We have successfully delivered 1500 in-depth solutions in areas like Marketing Analytics, Customer Analytics, Supply Chain Analytics, and more. For more information on our engagement policies and pricing plans, visit https://www.quantzig.com/request-for-proposal.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210203005424/en/
CONTACT: Quantzig
Eva Sharma
Marketing Manager
US: +1 630 538 7144
UK: +44 208 629 1455
https://www.quantzig.com/contact-us
KEYWORD:
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Quantzig
Copyright Business Wire 2021.
PUB: 02/03/2021 09:05 AM/DISC: 02/03/2021 09:05 AM
http://www.businesswire.com/news/home/20210203005424/en